Pain News and Research

Latest Pain News and Research

Researchers discover how Yersinia immobilizes immune system to spread within organs

Researchers at Tufts University School of Medicine and the Sackler School of Graduate Biomedical Sciences at Tufts have identified how one type of bacteria, Yersinia, immobilizes the immune system in order to grow in the organs of mice. To do so, the researchers extended the use of a technique and suggest that it could be used to study other bacteria that use the same or similar means of infection.

17 Sep 2013

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

A new study reports that workers exposed to crude oil and dispersants used during the Gulf oil spill cleanup display significantly altered blood profiles, liver enzymes, and somatic symptoms compared to an unexposed control group.

17 Sep 2013

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

The U.S. Food and Drug Administration today approved the first generic version of Xeloda (capecitabine), an oral chemotherapy pill used to treat cancer of the colon or rectum (colorectal cancer) that has spread to other parts of the body (metastatic), and metastatic breast cancer.

17 Sep 2013

Arginine therapy may be safe treatment for patients with sickle cell disease

Arginine therapy may be a safe and inexpensive treatment for acute pain episodes in patients with sickle cell disease, according to results of a recent clinical study. The study was the first randomized placebo-controlled study to demonstrate benefits of arginine therapy in children with sickle cell disease hospitalized for severe pain.

17 Sep 2013

Hyperthyroidism sounds urinary problem alarm

Physicians should be alert to urinary problems in women with hyperthyroidism, say researchers who found an association between the endocrine disorder and bladder pain syndrome/interstitial cystitis.

16 Sep 2013

Relmada Therapeutics collaborates with the Malvern Consulting Group

Relmada Therapeutics Inc., a clinical-stage company developing novel therapies for the treatment of chronic pain, today announced that has signed a collaboration agreement with the Malvern Consulting Group as clinical and regulatory advisor.

16 Sep 2013

New data demonstrates efficacy of GelrinC implant for treating articular cartilage in injured knees

Regentis Biomaterials announced today new clinical data demonstrating the efficacy and safety of its GelrinC implant for treating articular cartilage in injured knees. As presented at the International Cartilage Repair Society World Congress in Izmir, Turkey, the clinical results demonstrated sustained knee function improvement over 24 months after implantation and significant pain reduction.

16 Sep 2013

Study: Opioid prescribing for non-cancer pain increases

Prescribing of strong opioid medications for non-cancer pain in the United States has nearly doubled over the past decade, reports a study in the October issue of Medical Care, published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.

16 Sep 2013

$MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures$

MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures

DePuy Synthes CMF, a leader in skeletal and soft tissue repair and reconstruction, announced the launch of new instrumentation that enables less invasive surgical fixation and stabilization of rib fractures with the company's MatrixRIB System of precontoured, low-profile titanium plates, locking screws and intramedullary splints.

13 Sep 2013

Study reveals sadists seem to derive pleasure from behaviors that hurt others

Most of the time, we try to avoid inflicting pain on others - when we do hurt someone, we typically experience guilt, remorse, or other feelings of distress. But for some, cruelty can be pleasurable, even exciting. New research suggests that this kind of everyday sadism is real and more common than we might think.

13 Sep 2013

New Springer title explores history, social implications of the machines of sex research

Showtime viewers are looking forward to the widely anticipated new series, Masters of Sex, which tells the story of sex researchers William Masters and Virginia Johnson. And while Masters and Johnson may have been responsible for a part of the sexual revolution in America, what audiences may not know is how the tools used by these and other sex researchers have helped fuel both progress and oppression.

13 Sep 2013

Data shows Americans are living longer, reporting fewer symptoms of disease

Thanks to medical advances, better treatments and new drugs not available a generation ago, the average American born today can expect to live 3.8 years longer than a person born two decades ago.

13 Sep 2013

Using large doses of codeine may heighten sensitivity to pain

Using large and frequent doses of the pain-killer codeine may actually produce heightened sensitivity to pain, without the same level of relief offered by morphine, according to new research from the University of Adelaide.

13 Sep 2013

Study finds Americans enjoy more healthy years than a generation ago

The average American today can look forward to over two more years of healthy life than they could just a generation ago, Harvard researchers have found.

13 Sep 2013

NIH budget slashing may stall future pain research funding

Multi-faceted pain research discoveries within the last decade are bringing new hope for the estimated 100 million Americans with chronic pain. Unfortunately, translation of these scientific advances into clinical practice could be stalled without sufficient funding for both basic science and clinical pain research, according to the American Pain Society.

12 Sep 2013

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.

12 Sep 2013

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

arGEN-X, a clinical stage human monoclonal antibody therapeutics company, announces it has successfully generated potent antibody antagonists of Nav1.7, using its proprietary SIMPLE Antibody™ technology.

12 Sep 2013

Electroacupuncture treatment improves visceral hypersensitivity in irritable bowel syndrome

Irritable bowel syndrome patients extensively suffer from chronic visceral hypersensitivity, with involvement of all levels of the brain-gut axis, as well as various neurotransmitters.

12 Sep 2013

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

Clostridium difficile infection (CDI) treatment in a hospital setting using low dose oral vancomycin showed similar effectiveness compared to high dose, according to a new study by researchers at Montefiore Medical Center and Albert Einstein College of Medicine of Yeshiva University.

12 Sep 2013

FDA takes steps to restrict the use of pain meds

The Food and Drug Administration will require a class-wide label change for long-acting opioids aimed at limiting use of these drugs to patients with severe, refractory pain.

12 Sep 2013

Pain News and Research

Latest Pain News and Research

Researchers discover how Yersinia immobilizes immune system to spread within organs

Oil spill exposure appears to play role in development of hematologic and hepatic toxicity

First generic version of Xeloda gets FDA approval for breast and colorectal cancers

Arginine therapy may be safe treatment for patients with sickle cell disease

Hyperthyroidism sounds urinary problem alarm

Relmada Therapeutics collaborates with the Malvern Consulting Group

New data demonstrates efficacy of GelrinC implant for treating articular cartilage in injured knees

Study: Opioid prescribing for non-cancer pain increases

MatrixRIB MIPO instrumentation from DePuy Synthes CMF is more effective for rib fractures

Study reveals sadists seem to derive pleasure from behaviors that hurt others

New Springer title explores history, social implications of the machines of sex research

Data shows Americans are living longer, reporting fewer symptoms of disease

Using large doses of codeine may heighten sensitivity to pain

Study finds Americans enjoy more healthy years than a generation ago

NIH budget slashing may stall future pain research funding

Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine

arGEN-X generates potent antibody antagonists of Nav1.7 using SIMPLE Antibody technology

Electroacupuncture treatment improves visceral hypersensitivity in irritable bowel syndrome

Study finds low doses of vancomycin to be effective in treating serious C-difficile infection

FDA takes steps to restrict the use of pain meds

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Pain News and Research

Latest Pain News and Research

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Newsletters you may be interested in